Last reviewed · How we verify
NCT05776420: VOUCH4DIABETES
Effect of a Healthy Food Voucher on Blood Glucose Control in People With Type 2 Diabetes or Prediabetes
Phase 3 trial testing Food voucher in Diabete Type 2 in 390 participants. Currently enrolling.
1 April 2027
Quick facts
| Lead sponsor | Unity Health Toronto |
|---|---|
| Phase | Phase 3 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 390 |
| Start date | 21 March 2023 |
| Primary completion | 1 April 2027 |
| Estimated completion | 1 April 2027 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Food voucher
Conditions studied
- Diabete Type 2 — all drugs for Diabete Type 2 →
Sponsor
Unity Health Toronto — full company profile →
Who can join
19 and older, any sex, with Diabete Type 2. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized controlled trial (RCT) will determine if access to a voucher for healthy foods reduces blood sugar levels among people living on a low income who have type 2 diabetes or elevated blood sugar.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Voucher for Healthy Foods and Diabetes Control: A Randomized Clinical Trial.
Persaud N, Ul Haq MZ, Buadu A, Sabir A, et al · · 2025 · cited 6× · PMID 41114992 · DOI 10.1001/jamainternmed.2025.5420 -
Experiences of people with diabetes receiving a voucher for healthy foods: a qualitative study.
Ul Haq MZ, Sinha L, Nwebube C, Buadu A, et al · · 2026 · PMID 41664067 · DOI 10.1186/s12889-026-26436-y -
Assessing the Effect of a Food Voucher on the Dietary Intake of Patients with Diabetes Using the Canadian Diet History Questionnaire III: A Randomized Control Trial.
Buadu A, Ul Haq MZ, Sinha L, Sabir A, et al · · 2025 · PMID 40944252 · DOI 10.3390/nu17172865
Verify or expand the search:
- PubMed search for NCT05776420
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabete Type 2
Currently open trials in the same condition.
- NCT07506356 — Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors · recruiting
- NCT07467460 — Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disea · recruiting
- NCT07469943 — The Effect of Sodium Glucose Co-trnasportert Type 2 Inhibitors on Arterial Stiffness, Endothelial Glycocalyx Thickness a · recruiting
- NCT07495787 — Magnetic Compression Anastomosis Procedure for Partial Jejunoileal Anastomosis: Assessing the Viability of an Innovative · NA · recruiting
- NCT07212075 — Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups · recruiting
Other Unity Health Toronto trials
Trials by the same sponsor.
- NCT07507409 — Innovative Sternal Closure Techniques: Evaluating STRATAFIX™ and DERMABOND™ for Reduced Complications in CABG Patients · Phase 4 · not yet recruiting
- NCT07455487 — First Appendectomy Using Revolve Surgical Robotic Arm · NA · not yet recruiting
- NCT07301632 — Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial · Phase 2 · recruiting
- NCT07314905 — Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp) · Phase 3 · not yet recruiting
- NCT06571916 — Brief Skills for Safer Living (Brief-SfSL) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05776420 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Unity Health Toronto
- Last refreshed: 10 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05776420.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing